Next Article in Journal
In Memoriam Dr. André Mischke
Previous Article in Journal
Development of Novel API-ILs for the Optimization of Anti-Alzheimer Drugs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole †

by
Verónica Fernandez-Stefanuto
and
Emilia Tojo
*
Faculty of Chemistry, University of Vigo, Marcosende, As Lagoas, 36210 Vigo, Spain
*
Author to whom correspondence should be addressed.
Presented at the 22nd International Electronic Conference on Synthetic Organic Chemistry, 15 November–15 December 2018; Available Online: https://sciforum.net/conference/ecsoc-22.
Proceedings 2019, 9(1), 48; https://doi.org/10.3390/ecsoc-22-05781
Published: 14 November 2018

Abstract

The transformation of two solid Active Pharmaceutical Ingredients (APIs) into new ionic liquids (IL)s that incorporate APIs (API-ILs) is reported. The structures of the APIs (indomethacin and mebendazole) were selected by their susceptibility to being transformed into API-ILs (either to form the cation or the anion) and their limited bioavailability due to their low solubility in water. The counterions, such as those derived from 2-dimethylaminoethanol (DMEA), tetramethylguanidine (TMG), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,4-diazabicyclo[2.2.2] (TED), <i>p</i>-toluensulfonic acid, glycolic acid, methanesulfonic acid, and saccharin, were carefully chosen, aiming for high biocompatibility, low toxicity, and high water solubility. The synthesis was carried out by direct treatment of the API with the corresponding selected acid or base. Finally, the solubility in water of all the synthesized salts was determined.
Keywords: ionic liquid; active pharmaceutical ingredients; water solubility ionic liquid; active pharmaceutical ingredients; water solubility

Share and Cite

MDPI and ACS Style

Fernandez-Stefanuto, V.; Tojo, E. New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole. Proceedings 2019, 9, 48. https://doi.org/10.3390/ecsoc-22-05781

AMA Style

Fernandez-Stefanuto V, Tojo E. New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole. Proceedings. 2019; 9(1):48. https://doi.org/10.3390/ecsoc-22-05781

Chicago/Turabian Style

Fernandez-Stefanuto, Verónica, and Emilia Tojo. 2019. "New Active Pharmaceutical Ingredient-Ionic Liquids (API-ILs) Derived from Indomethacin and Mebendazole" Proceedings 9, no. 1: 48. https://doi.org/10.3390/ecsoc-22-05781

Article Metrics

Back to TopTop